For purchasing or obtaining a quotation, please visit the Distributor page
to find your local distributor.
to find your local distributor.
HOME > Product search results
Product（862）
[-] MHC tetramer（862）
>Class I（862）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M224-1 |
HLA-A*02:01 CDC37L1 Neoepitope Tetramer-FLSDHLYLV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLSDHLYLV | ４°C | |||||
|
|
TS-M212-1 |
HLA-A*02:01 CLPP Neoepitope Tetramer-ILDKVLVHL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILDKVLVHL | ４°C | |||||
|
|
TS-M204-1 |
HLA-A*02:01 HCV polyprotein Tetramer-YLLPRRGPRL-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLPRRGPRL | 35-44 | ４°C | ||||
|
|
TC-8019-1 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | ４°C | ||||
|
|
TS-M267-2 |
HLA-A*24:02 LOK Tetramer-SYQKVIELF-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| SYQKVIELF | 289-297 | ４°C | ||||
|
|
TS-M261-2 |
HLA-A*11:01 MATN2 Neoepitope Tetramer-KTLTSVFQK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| KTLTSVFQK | ４°C | |||||
|
|
TS-M243-2 |
HLA-A*02:01 UGCGL2 Neoepitope Tetramer-GLLDEDFYA-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLDEDFYA | ４°C | |||||
|
|
TS-M240-2 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLAI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLAI | ４°C | |||||
|
|
TS-M226-2 |
HLA-A*02:01 Astrotactin-1 Neoepitope Tetramer-KLYGLDWAEL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLYGLDWAEL | ４°C | |||||
|
|
TS-M223-2 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-VLENFTIFLV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLENFTIFLV | ４°C | |||||
|
|
TS-M216-2 |
HLA-A*02:01 HAUS3 Neoepitope Tetramer-ILNAMIAKI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILNAMIAKI | ４°C | |||||
|
|
TS-M210-2 |
HLA-A*02:01 AHNAK Neoepitope Tetramer-FMPDFDLHL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMPDFDLHL | ４°C | |||||
|
|
TS-M201-2 |
HLA-A*01:01 TRIP12 Neoepitope Tetramer-PSDTRQMLFY-APC |
|
|||
|
|
cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| PSDTRQMLFY | ４°C | |||||
|
|
TS-M277-1 |
HLA-B*08:01 FAM50B Neoepitope Tetramer-DMKARQKALV-PE |
|
|||
|
|
cancer | PE | B*08:01 | 50 tests |
0 (Contact us) |
|
| DMKARQKALV | ４°C | |||||
|
|
TS-M221-1 |
HLA-A*02:01 GANAB Neoepitope Tetramer-ALYGFVPVL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYGFVPVL | ４°C | |||||
|
|
TS-M219-1 |
HLA-A*02:01 SMARCD3 Neoepitope Tetramer-KLFEFLVYGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLFEFLVYGV | ４°C | |||||
|
|
TS-M214-1 |
HLA-A*02:01 COL18A1 Neoepitope Tetramer-VLLGVKLFGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLLGVKLFGV | ４°C | |||||
|
|
TC-8007-1 |
HLA-A*02:01 P53168-176 Tetramer-HMTEVVRRC-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRRC | 168-176 | ４°C | ||||
|
|
TS-M270-2 |
HLA-B*07:02 KIF16B Neoepitope Tetramer-APARLERRHSA-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| APARLERRHSA | ４°C | |||||
|
|
TS-M265-2 |
HLA-A*24:02 β-catenin Neoepitope Tetramer-SYLDSGIHF-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| SYLDSGIHF | ４°C | |||||
|
|
TS-M236-2 |
HLA-A*02:01 PGM5 Neoepitope Tetramer-QQFAVGSYV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| QQFAVGSYV | ４°C | |||||
|
|
TS-M233-2 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-SVLENFTIFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SVLENFTIFL | ４°C | |||||
|
|
TS-M231-2 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| NLNCCSVPV | ４°C | |||||
|
|
TS-M238-1 |
HLA-A*02:01 SNAT1 Neoepitope Tetramer-ILAALFLGL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAALFLGL | ４°C | |||||
|
|
TS-M235-1 |
HLA-A*02:01 Filamin-A Neoepitope Tetramer-HIAKSLFEV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HIAKSLFEV | ４°C | |||||
|
|
TS-M233-1 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-SVLENFTIFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SVLENFTIFL | ４°C | |||||
|
|
TS-M228-1 |
HLA-A*02:01 PGML5 Neoepitope Tetramer-AVGSYVYSV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVGSYVYSV | ４°C | |||||
|
|
TS-M209-1 |
HLA-A*02:01 SRPX Neoepitope Tetramer-TLWCSPIKV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| TLWCSPIKV | ４°C | |||||
|
|
TS-M208-1 |
HLA-A*02:01 p53 Neoepitope Tetramer-VVPCEPPEV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVPCEPPEV | ４°C | |||||
|
|
TC-8020-1 |
HLA-A*02:01 PSMA663-671 Tetramer-MMNDQLMFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| MMNDQLMFL | 663-671 | ４°C | ||||
|
|
TS-M266-2 |
HLA-A*24:02 COASY Neoepitope Tetramer-RFLEYLPLRF-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| RFLEYLPLRF | ４°C | |||||
|
|
TS-M245-2 |
HLA-A*02:01 Sarcospan Neoepitope Tetramer-LMASISSFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMASISSFL | ４°C | |||||
|
|
TS-M242-2 |
HLA-A*02:01 MCT2 Neoepitope Tetramer-AMAGSLVFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AMAGSLVFL | ４°C | |||||
|
|
TS-M237-2 |
HLA-A*02:01 GCN1 Neoepitope Tetramer-ALLETPSLLL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLETPSLLL | ４°C | |||||
|
|
TS-M227-2 |
HLA-A*02:01 KMT2D Neoepitope Tetramer-ALSPVIPHI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALSPVIPHI | ４°C | |||||
|
|
TS-M213-2 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ACDPHSGHFV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ACDPHSGHFV | ４°C | |||||
|
|
TS-M212-2 |
HLA-A*02:01 CLPP Neoepitope Tetramer-ILDKVLVHL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILDKVLVHL | ４°C | |||||
|
|
TS-M207-2 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ALDPHSGHFV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDPHSGHFV | ４°C | |||||
|
|
TS-M204-2 |
HLA-A*02:01 HCV polyprotein Tetramer-YLLPRRGPRL-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLPRRGPRL | 35-44 | ４°C | ||||
|
|
TS-M215-1 |
HLA-A*02:01 WDR46 Neoepitope Tetramer-FLIYLDVSV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLIYLDVSV | ４°C | |||||
|
|
TS-M254-2 |
HLA-A*03:01 MYO1B Neoepitope Tetramer-KINKNPKYK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KINKNPKYK | ４°C | |||||
|
|
TS-M240-1 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLAI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLAI | ４°C | |||||
|
|
TS-M234-1 |
HLA-A*02:01 GAS7 Neoepitope Tetramer-SLADEAEVYL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLADEAEVYL | ４°C | |||||
|
|
TS-M225-1 |
HLA-A*02:01 Hsp70 Neoepitope Tetramer-SLFEGIDIYT-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFEGIDIYT | ４°C | |||||
|
|
TS-M275-2 |
HLA-B*07:02 MYADM Neoepitope Tetramer-SPMIVGSPW-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| SPMIVGSPW | ４°C | |||||
|
|
TS-M229-2 |
HLA-A*02:01 SNX24 Neoepitope Tetramer-KLSHQLVLL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLSHQLVLL | ４°C | |||||
|
|
TS-M209-2 |
HLA-A*02:01 SRPX Neoepitope Tetramer-TLWCSPIKV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| TLWCSPIKV | ４°C | |||||
|
|
TS-M239-1 |
HLA-A*02:01 SPOP Neoepitope Tetramer-FLLDEAIGL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLDEAIGL | ４°C | |||||
|
|
TC-8024-1 |
HLA-A*02:01 KRAS5-14 WT Tetramer-KLVVVGAGGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAGGV | 5-14 | ４°C | ||||
|
|
TS-M277-2 |
HLA-B*08:01 FAM50B Neoepitope Tetramer-DMKARQKALV-APC |
|
|||
|
|
cancer | APC | B*08:01 | 50 tests |
0 (Contact us) |
|
| DMKARQKALV | ４°C | |||||
|
|
TS-M244-2 |
HLA-A*02:01 FNDC3B Neoepitope Tetramer-VVMSWAPPV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVMSWAPPV | ４°C | |||||
|
|
TS-M218-1 |
HLA-A*02:01 ACTN1 Neoepitpe Tetramer-FIASNGVKLV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FIASNGVKLV | ４°C | |||||
|
|
TS-M217-1 |
HLA-A*02:01 ME3 Neoepitope Tetramer-FLDEFMEGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDEFMEGV | ４°C | |||||
|
|
TS-M241-2 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLA-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLA | ４°C | |||||
|
|
TS-M220-2 |
HLA-A*02:01 PRDX5 Neoepitope Tetramer-LLLDDLLVSI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLDDLLVSI | ４°C | |||||
|
|
TS-M206-1 |
HLA-A*02:01 HCV polyprotein Tetramer-LLFNILGGWV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFNILGGWV | 1807-1816 | ４°C | ||||
|
|
TS-M228-2 |
HLA-A*02:01 PGML5 Neoepitope Tetramer-AVGSYVYSV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVGSYVYSV | ４°C | |||||
|
|
TS-M205-2 |
HLA-A*02:01 HCV polyprotein Tetramer-DLMGYIPLV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| DLMGYIPLV | 132-140 | ４°C | ||||
|
|
TS-M222-1 |
HLA-A*02:01 NSDHL Neoepitope Tetramer-ILTGLNYEV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILTGLNYEV | ４°C | |||||
|
|
TC-8020-2 |
HLA-A*02:01 PSMA663-671 Tetramer-MMNDQLMFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| MMNDQLMFL | 663-671 | ４°C | ||||
|
|
TS-M245-1 |
HLA-A*02:01 Sarcospan Neoepitope Tetramer-LMASISSFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMASISSFL | ４°C | |||||
|
|
TS-M236-1 |
HLA-A*02:01 PGM5 Neoepitope Tetramer-QQFAVGSYV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| QQFAVGSYV | ４°C | |||||
- The availability is based on the information in Japan at 00:05, Jun 6, 2026 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.